What Is Genetic Peptide Testing? 14 Pathways, 49 Peptides Explained

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on peptides and GLP-1. Browse all Peptides & GLP-1 education

The peptide category has exploded. GLP-1 protocols for weight management, growth hormone axis peptides for muscle and recovery, PDE5 and melanocortin pathways for sexual health, methylation-supporting peptides for longevity. More options than ever — and almost no personalization underneath any of it. The missing variable is your DNA. Genetic peptide testing is the category of DNA analysis that fixes that gap by focusing specifically on the biological pathways peptide protocols engage. The PlexusDx Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, and 150+ genetic insights — so the conversation with your provider starts with your actual biology rather than a generic brochure.

What Genetic Peptide Testing Actually Does

Genetic peptide testing is not a drug-response predictor. It is a pathway map. Your DNA carries common variants in genes that regulate the signaling systems peptide protocols target — the GLP-1 receptor, the growth hormone axis, nitric oxide production, estrogen clearance, androgen sensitivity, sirtuin activation, and more. A genetic peptide test identifies those variants, places them in biological context, and shows which pathways in your body run fast, slow, or somewhere in between. That map lets you and your healthcare provider make a more informed decision about which protocol categories fit your biology — and which probably don't.

The 14 Pathways Your DNA Shapes

The PlexusDx panel covers 14 interconnected pathways, each with its own insight count. Weight Management leads with 34 insights — the most genetically-studied peptide-related category. Longevity & Aging follows with 17 insights, Muscle Growth with 15, Skin Health with 14, and Energy Metabolism with 12. Immunity delivers 11 insights, Tissue Repair 9, and Mood 8. The remaining pathways each focus a targeted system: Cognition, Inflammation, Reproductive Health, and Sexual Health at 6 insights each, Brain Health at 4, and Sleep at 3. That totals 150+ insights spanning 48 unique genes and 57 unique SNPs — every one tied to a published, peer-reviewed functional relationship.

49 Peptides — Why That Number Matters

Peptides are short chains of amino acids that act as biological signals. Some occur naturally in the body; others are synthesized for therapeutic or wellness use. The PlexusDx panel covers 49 distinct peptides across the major categories — GLP-1 receptor agonists, growth hormone axis peptides, melanocortin pathway peptides, PDE5 inhibitors, vasoactive peptides, methylation support peptides, and more. The test does not analyze response to any single compound. Instead, it maps the underlying genetic architecture of the pathways that all 49 peptides interact with. That architecture is stable — once you know your profile, it applies across protocols for life.

Named Gene Variants That Shape Your Response

The insights aren't abstract. Each one ties to a specific, peer-reviewed gene variant with documented functional impact across peptide-related pathways.

FTO (rs9939609) — the "obesity gene" — influences appetite regulation and weight management response.

GLP1R — variants in the GLP-1 receptor itself, shaping how your body responds to GLP-1 pathway signaling.

FOXO3 — the "longevity gene," associated with centenarian populations and cellular repair capacity.

ACTN3 (R577X) — the "sprint gene," shaping muscle fiber type composition and hypertrophy response.

COMT (Val158Met) — governs estrogen clearance speed and catecholamine metabolism.

MTHFR (C677T, A1298C) — sets your baseline methylation capacity, which feeds into multiple other pathways.

eNOS (NOS3) — drives nitric oxide production, central to vascular function and sexual health.

SHBG — regulates free testosterone availability in both men and women.

Each variant sits in one of 14 pathways, and most interact with more than one. That cross-pathway behavior is why a narrow, single-gene test delivers a narrow answer — and why a 48-gene, 14-pathway panel delivers usable understanding.

How the Test Works — From Saliva to Insight

The process is simple. A saliva sample collected at home is processed on the Illumina Global Screening Array at CLIA-certified labs. The platform analyzes 57 unique SNPs across 48 unique genes tied to peptide-related pathways. Results are delivered through the secure PlexusDx Results Portal — each insight paired with pathway context, actionable guidance, and cross-references to the broader panel. No needles, no clinic visits, no repeat testing. Your DNA doesn't change, so one test informs every future peptide decision across your lifetime.

How Your Results Connect to Protocol Decisions

The panel is organized to align with the five protocol families that peptide telehealth has consolidated around. Each family has a pillar guide that explains how that family's specific gene variants translate into pathway-level decisions:

The Complete Guide to Genetic Longevity Testing — FOXO3, SOD2, APOE, SIRT1, TERT, and 12 other longevity insights.

The Complete Guide to Genetic Muscle Growth Testing — ACTN3, IGF1, MSTN, GHSR, GHR, and 10 other muscle insights.

The Complete Guide to Genetic Men's Hormone Testing — SHBG, CYP19A1, AR, SRD5A2, and related androgen pathway insights.

The Complete Guide to Genetic Women's Hormone Testing — COMT, CYP1A1, CYP1B1, MTHFR, ESR1, and related estrogen pathway insights.

The Complete Guide to Genetic Sexual Health Testing — eNOS, MTNR1B, DRD2, OXTR, and related sexual health pathway insights.

Genetics as a Guide, Not a Guarantee

Results don't determine outcomes. They reveal the shape of your biological baseline — where your pathways run efficiently and where they need more deliberate support. Peptide protocols work better when they respect your actual biology rather than a generic protocol copied from a podcast. That's the entire premise of test before you invest: genetics as a guide, not a guarantee, and always interpreted alongside symptoms, bloodwork, and a qualified healthcare provider's clinical judgment. PlexusDx tells you about your biology. It does not tell you what to put in your body.

The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways. It does not recommend, prescribe, or determine which peptides you should use. Consult a qualified healthcare provider before beginning any peptide protocol.

Ready to map the 14 pathways, 49 peptides, and 150+ insights coded into your DNA? Take the Precision Peptide Genetic Test

Frequently Asked Questions

What is genetic peptide testing?

The Precision Peptide Genetic Test analyzes DNA variants across 14 pathways and 49 peptides — mapping the biological architecture peptide protocols target. That includes GLP-1 signaling, growth hormone axis, nitric oxide, and estrogen clearance. Results deliver 150+ insights total. The test maps pathway function — it does not predict response to specific compounds.

How is genetic peptide testing different from other genetic tests?

The Precision Peptide Genetic Test is pathway-focused, not trait-focused. Consumer DNA tests score broad categories like ancestry or disease risk. Genetic peptide testing isolates 48 genes and 57 SNPs tied specifically to pathways peptide protocols engage — a precision map of 150+ insights aligned to the decisions ahead of you.

Do I need genetic testing before starting a peptide protocol?

Not legally — but increasingly, informed providers recommend it. The Precision Peptide Genetic Test reveals baseline pathway function across FTO, GLP1R, FOXO3, ACTN3, COMT, MTHFR, eNOS, and more. Knowing that profile before committing to a protocol is the "test before you invest" approach — turning guesswork into a conversation grounded in your actual biology.

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education